FEB 21 - 22 2018 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Drug Discovery 2018
15 7 1663

Despite the rapid pace of scientific advances that garner a better understanding of a myriad of diseases on their molecular level, modern drug discovery is a long, complex process. While on the one side, new medicines offer more manageable side effects, fewer hospitalizations, and increased productivity, each new drug is up against the scientific, technical, and regulatory challenges related to drug development

As to be expected, the course of action for researching and developing new medicines is growing in difficulty and length. It can take anywhere from 10 or more years for a drug to reach the marketplace, toting a price tag of an estimated $2.6 billion. It is in this landscape that LabRoots is proud to announce its newest addition to the virtual event line up – Drug Discovery 2018!

Industry leaders from around the world will join together and discuss the advancements, challenges and successes of discovery and developing new medicines during this free, two-day event. Topics to be discussed include:

  • GPCR Drug Discovery     

  • Biomarkers in early-stage drug development

  • Pharmacogenomics and Personalized Medicine     

  • Emerging Trends
     

LabRoots virtual conferences allow you to participate in a global setting, with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global neuroscience community with a high degree of interaction through live-streaming video and chat sessions.
 

Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2018 Drug Discovery Virtual Event. Submission is free. Submit your abstract here
 

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation, you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
 

Use #LRdrug to follow the conversation!


Speakers:
  • Chief, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital, Professor of Pathology and Epidemiology, Harvard Medical School, Dana-Farber Cancer Institute
  • Associate Professor & Director, Center for Pharmacogenomics, University of Florida College of Pharmacy
  • Assistant Professor of Microbiology, Immunology, & Tropical Medicine at The George Washington University
  • Chief Scientific Officer, Vaccibody AS
  • Professor, Associated Laboratory Director, Saint-Luc University Hospital, Brussels, Belgium
  • Michael Hooker Distinguished Professor, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy
  • Business Development Manager at AroCell AB
  • Professor and Department Chair, Chemical Engineering, Art Zafiropoulo Chair in Engineering, Affiliated Faculty, Bioengineering, Northeastern University, College of Engineering

Show Resources
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Agenda
All times are Pacific Time
  • FEB 21, 2018 07:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Evolving Paradigms of Pharmaco-MPE (Molecular Pathological Epidemiology) and Immuno-MPE for Precision Medicine
    Speaker: Shuji Ogino, MD, PhD, MS
  • FEB 21, 2018 10:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Developing Personalized Cancer Neoantigen Vaccines
    Speaker: Agnete Fredriksen, MSc, PhD
  • FEB 21, 2018 10:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Effects of Epigenetic Therapies on the Tumor and Host Immune System
    Speaker: Katherine Chiappinelli, PhD
  • Pharmacogenomics and Personalized Medicine
  • FEB 21, 2018 07:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Evolving Paradigms of Pharmaco-MPE (Molecular Pathological Epidemiology) and Immuno-MPE for Precision Medicine
    Speaker: Shuji Ogino, MD, PhD, MS
  • Emerging Trends
  • FEB 21, 2018 10:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Developing Personalized Cancer Neoantigen Vaccines
    Speaker: Agnete Fredriksen, MSc, PhD
  • FEB 21, 2018 10:30 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Effects of Epigenetic Therapies on the Tumor and Host Immune System
    Speaker: Katherine Chiappinelli, PhD
Speakers

  • Shuji Ogino, MD, PhD, MS
    Chief, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital, Professor of Pathology and Epidemiology, Harvard Medical School, Dana-Farber Cancer Institute
    Biography
      Dr. Shuji Ogino is Professor (of Pathology and Epidemiology) at Dana-Farber Cancer Institute, Brigham and Women's Hospital (BWH), Harvard Medical School, and Harvard T.H. Chan School of Public Health; the founding Chief of Program in MPE Molecular Pathological Epidemiology at BWH; and an Associate Member of Broad Institute of MIT and Harvard. Dr. Ogino has been developing the transdisciplinary science "Molecular Pathological Epidemiology (MPE)", which bridges and integrates molecular biologic and population health sciences. Since 2013, he has been the Chairperson for The International MPE Meeting Series, and the Fourth International MPE Meeting will be held in Boston in 2018 (www.mpemeeting.org). Dr. Ogino has received numerous awards and honors, including CAP Foundation Scholars Award; USCAP Ramzi Cotran Young Investigator Award; Executive Officer's Award and Meritorious Service Award from AMP; recognitions of "Most Influential Scientific Minds" in 2014, and "Highly Cited Researcher" in 2015, 2016, and 2017 by Thomson Reuters and Clarivate Analytics; elected membership in ASCI; membership of FASEB Excellence in Science Award Committee; and membership of various NIH study sections, most notably NCI R35 Outstanding Investigator Award (OIA) Special Emphasis Panel in 2016. Dr. Ogino has been a recipient of prestigious NCI R35 OIA grant, which represent 7-year funding for me to pursue paradigm-shifting high impact research.
    • Larisa Cavallari, Pharm. D.
      Associate Professor & Director, Center for Pharmacogenomics, University of Florida College of Pharmacy
      Biography
        Larisa H. Cavallari, Pharm.D., is an Associate Professor and Associate Chair in the Department of Pharmacotherapy and Translational Research, Director of Center for Pharmacogenomics, and Associate Director of the Personalized Medicine Program at the University of Florida. She received her Pharm.D. degree from the University of Georgia, followed by a pharmacy practice residency at the VA Medical Center in Memphis, Tennessee and a fellowship in cardiovascular pharmacogenomics at the University of Florida. Her research involves discovery of genetic associations with drug response and their translation into clinical practice. Her research is currently funded by the NIH and FDA in addition to receiving industry support.
      • Katherine Chiappinelli, PhD
        Assistant Professor of Microbiology, Immunology, & Tropical Medicine at The George Washington University
        Biography
          Katherine Bakshian Chiappinelli, Ph.D., joined the GW Department of Microbiology, Immunology and Tropical Medicine University in 2017 as an Assistant Professor.Dr. Chiappinelli graduated with a B.S. in Biology and Music from Haverford College in 2007 and received her Ph.D. in Developmental, Regenerative, and Stem Cell Biology from Washington University in St. Louis under the supervision of Dr. Paul Goodfellow in 2012. Dr. Chiappinelli pursued postdoctoral studies at Johns Hopkins University with Dr. Stephen Baylin investigating the epigenetic control of immune signaling in cancer cells. Her research focuses on how epigenetic therapies can be used against cancers, specifically in the context of arming the host immune system to fight cancer cells.
        • Agnete Fredriksen, MSc, PhD
          Chief Scientific Officer, Vaccibody AS
          Biography
            Agnete B. Fredriksen is Co-Founder and joined Vaccibody in 2007. She holds a MSc, PhD from Institute of Immunology, Rikshospitalet Medical Center in Oslo where she designed and developed the first Vaccibody vaccine molecules. She received the King's Gold Medal for her PhD thesis describing Vaccibodies. Her focus is on cancer vaccines from idea to clinical development. Previous employment includes Affitech AS and Medinnova AS. Agnete is author on numerous scientific papers in the field of immunology, immunotherapy and vaccines. Inventor on several patents in the field of immunotherapy. She is board member for the BIA programme of NRC stimulating research in the Norwegian industry.
          • Damien Gruson, PhD
            Professor, Associated Laboratory Director, Saint-Luc University Hospital, Brussels, Belgium
            Biography
              Professor Damien Gruson was awarded his degree of Pharmacist and later of Specialist in Laboratory Medicine from the Catholic University of Louvain, Brussels, Belgium. He joined the Department of Laboratory Medicine of the St-Luc University Hospital in 2008. He is now associated laboratory director and leading Endocrine Biology. He is also member of the research unit on Endocrinolgy Diabetes and Nutrition of the Catholic University of Louvain. Pr. D. Gruson has published numerous articles in several international peer-reviewed journals. Pr. D. Gruson is a member of the committee on distance learning of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), of the IFCC task force for young scientists (Chair between 2010 and 2012 and now consultant), a member of the division of Endocrinology of the American Association of Clinical Chemistry. Pr. D. Gruson is also a Fellow of the European Society of Cardiology.
            • Bryan L. Roth, MD, PhD
              Michael Hooker Distinguished Professor, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy
              Biography
                Bryan L. Roth MD, PhD is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Chapel Hill School of Medicine. Dr. Roth received his MD and PhD (Biochemistry) from St. Louis University in 1983 and subsequently training in pharmacology (NIH), molecular biology and psychiatry (Stanford) . Dr. Roth has published more than 400 papers in the general area of the molecular pharmacology of drug actions, including a large number of papers published in Science, Nature and Cell over the past decade. Dr. Roth has more than 40 patents and has founded 2 companies. Dr. Roth has been elected to the National Academy of Medicine of the National Academy of Sciences and has received many honors including the Goodman and Gilman Award for Receptor Pharmacology (ASPET; 2016), the PhRMA Foundation Excellence in Pharmacology Award, and a NARSAD Distinguished Investigator Award. Dr. Roth also given many endowed lectures including the Goodman, Koppyani, Strongwater, Niznik, Swammerdam, Lowenthal, S.G. Fergusson, Chauncy Leake and Philip S. Portoghese Lectures. Dr. Roth has also been named the 2018 IUHPAR Lecturer in Analytical Pharmacology (IUPHAR), the 2017 Martin S. Rodbell Lecturer and the inaugural 2017 Elliot Saul Vessell Visiting Professor. Dr. Roth has also been named a Thompson Reuters 'Highly Cited Scientist' in Pharmacology and in Biology and Biochemistry.
              • Martin Shaw
                Business Development Manager at AroCell AB
                Biography
                  Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as qualified for use in toxicological testing. He developed strong relationships with hospitals, clinical research organizations and pharmaceutical companies, including AstraZeneca, Sanofi Aventis, Pfizer, Novartis, Merck, Glaxo Smith Kline and Johnson and Johnson. From 1975-1992 Martin Shaw filled many technical and marketing roles at Pharmacia Diagnostics (now Thermo-Fisher). He and his coworkers developed and introduced the first commercial tests for neonatal hypothyroidism, celiac disease, and a range of novel biomarkers to monitor allergy and inflammation. Bringing testing close to the patient is important and Martin brings this experience from being Marketing Manager at Magnasense Technologies, Finland, where he introduced and promoted a novel point-of-care test system based on magnetically labelled antibodies. Martin has published several peer-reviewed articles on biomarkers and presented at many scientific congresses, including being guest speaker at the FDA.
                • Thomas Webster, PhD
                  Professor and Department Chair, Chemical Engineering, Art Zafiropoulo Chair in Engineering, Affiliated Faculty, Bioengineering, Northeastern University, College of Engineering
                  Biography
                    Thomas J. Webster's (H index: 80, Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). Prof. Webster is the current director of the Nanomedicine Laboratories (currently at 23 members) and has completed extensive studies on the use of nanophase materials in medicine. He pioneered the use of nanomaterials to increase tissue growth, inhibit infection, and decrease inflammation. He was appointed Department Chair of Chemical Engineering at Northeastern University in 2012 in which the Department recently broke the record for the fastest increase in ranking over a five year period from the U.S. News and World Report. In his 17 years in academics, Prof. Webster has graduated/supervised over 149 visiting faculty, clinical fellows, post-doctoral students, and thesis completing B.S., M.S., and Ph.D. students. To date, his lab group has generated over 13 textbooks, 68 book chapters, 376 invited presentations, at least 503 peer-reviewed literature articles and/or conference proceedings, at least 767 conference presentations, and 42 provisional or full patents. His research has led to the formation of 12 companies with 4 FDA approved nanomedicine products. He is the founding editor-in-chief of the International Journal of Nanomedicine (the first open-access, international journal in nanomedicine which has a 5-year impact factor of 5.03). Prof. Webster currently directs or co-directs several centers in the area of biomaterials: The Center for Natural and Tropical Biomaterials (Medellin, Colombia), The Center for Pico and Nanomedicine (Wenzhou China), and The International Materials Research Center (Soochow, China). He was named the Art Zafiropoulo Chair at Northeastern University for his contributions to nanomedicine in 2013. Prof. Webster has received numerous honors including but not limited to: 2012, Fellow, American Institute for Medical and Biological Engineering (AIMBE, representing the top 2% of all medical and biological engineers); 2013, Fellow, Biomedical Engineering Society; 2015, Wenzhou 580 Award; 2015, Zheijang 1000 Talent Program; 2016, International Materials Research Chinese Academy of Science Lee-Hsun Lecture Award; 2016, International College of Fellows, Biomaterials Science and Engineering; and 2016, Acta Biomaterialia Silver Award. He also served as the President of the U.S. Society For Biomaterials. He has appeared on BBC, NBC, ABC, Fox News, the Weather Channel, the Discovery Channel, and the recent special 'Year Million' TV series on National Geographic talking about the future of medicine and science.
                  Sponsored By

                  For information on becoming a sponsor or exhibitor, please click here.


                  Continuing Education (CME/CE/CEU) Credits

                  The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                  Help

                  General LabRoots Questions

                  For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                  Contact us

                  Virtual Events and Webinars

                  Supported Configurations

                  • Operating System Internet Explorer Firefox Chrome Safari
                    Vista IE8+ FF10+ Chrome15+
                    Windows 7 IE8+ FF10+ Chrome15+
                    Windows 8 IE10 FF10+ Chrome15+
                    Mac OS X   FF10+ Chrome15+ Safari5.1+
                  • Cookie settings: session cookies enabled
                  • Browser configuration must have JavaScript enabled
                  • Adobe Flash player 10.2 or later

                  To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                  Internet Connection

                  • A minimum of 100Kbps is recommended for audio-only events
                  • A minimum of 300Kbps is recommended for speaker on-video events

                  Computer Equipment

                  • Screen Resolution: Minimum 1024x768
                  • Video Card: 65,000 colors minimum
                  • Sound card and speakers (or headphones) for hearing webcast in full format
                  • Audio Card: 16-bit minimum
                  • RAM: 512MB of free RAM

                  Firewall Protocol

                  • HTTP on port 80 or HTTPS on port 443
                  • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                  • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                  Work-At-Home Attendees

                  • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                  For A Seamless Experience

                  When using a mobile device, FREE Mobile Apps are available:

                  - For viewing Webinars:

                  - For viewing Virtual Events

                  Attendee Guide

                  • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                  Virtual Event and Webinar Support:

                  Continuing Education (CME/CE) Support

                  Loading Comments...
                  Show Resources
                  Event Countdown
                  • 0 Days
                  • 0 Hours
                  • 0 Minutes
                  • 0 Seconds